Discovery of OATD-01, a First-in-Class Chitinase Inhibitor as Potential New Therapeutics for Idiopathic Pulmonary Fibrosis-Reference-Cited by-同舟云学术

Discovery of OATD-01, a First-in-Class Chitinase Inhibitor as Potential New Therapeutics for Idiopathic Pulmonary Fibrosis

Published:2020-10-20 Issue:24 Volume:63 Page:15527-15540
ISSN:0022-2623
Container-title:Journal of Medicinal Chemistry
language:en
Short-container-title:J. Med. Chem.

Author:

Koralewski Robert¹,Dymek Barbara¹,Mazur Marzena¹,Sklepkiewicz Piotr¹,Olejniczak Sylwia¹,Czestkowski Wojciech¹,Matyszewski Krzysztof¹,Andryianau Gleb¹,Niedziejko Piotr¹,Kowalski Michal¹,Gruza Mariusz¹,Borek Bartłomiej¹,Jedrzejczak Karol¹,Bartoszewicz Agnieszka¹,Pluta Elżbieta¹,Rymaszewska Aleksandra¹,Kania Magdalena¹,Rejczak Tomasz¹,Piasecka Sylwia¹,Mlacki Michal¹,Mazurkiewicz Marcin¹,Piotrowicz Michał¹^ORCID,Salamon Magdalena¹,Zagozdzon Agnieszka¹,Napiorkowska-Gromadzka Agnieszka²,Bartlomiejczak Aneta²,Mozga Witold¹,Dobrzański Paweł¹,Dzwonek Karolina¹,Golab Jakub¹³,Nowotny Marcin²^ORCID,Olczak Jacek¹^ORCID,Golebiowski Adam¹^ORCID

Affiliation:

1. OncoArendi Therapeutics SA, Żwirki i Wigury 101, 02-089 Warsaw, Poland

2. Structural Biology Center, International Institute of Molecular and Cell Biology, Trojdena 4, 02-109 Warsaw, Poland

3. Department of Immunology, Medical University of Warsaw, Nielubowicza 5, 02-097 Warsaw, Poland

Funder

European Regional Development Fund

Narodowe Centrum Badan i Rozwoju

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Molecular Medicine

Link